OmniPod: Why is it Still Not Covered under Medicare?

In an opinion editorial for the Morning Consult, George Grunberger, M.D., chairman of the Grunberger Diabetes Institute, urges the Centers of Medicare and Medicaid Services (CMS which operates the Medicare program) to reverse its non-coverage policy on FDA-approved insulin delivery system, OmniPod. Read column here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.